Bile Duct Neoplasms

"Bile Duct Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors or cancer of the BILE DUCTS.

Descriptor ID	D001650
MeSH Number(s)	C04.588.274.120.250 C06.130.120.120 C06.130.320.120 C06.301.120.250
Concept/Terms	Bile Duct Neoplasms Bile Duct Neoplasms Bile Duct Neoplasm Neoplasm, Bile Duct Neoplasms, Bile Duct Bile Duct Cancer Bile Duct Cancer Bile Duct Cancers Cancer, Bile Duct Cancers, Bile Duct Cancer of the Bile Duct Cancer of Bile Duct

Below are MeSH descriptors whose meaning is more general than "Bile Duct Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Digestive System Neoplasms [C04.588.274]
Biliary Tract Neoplasms [C04.588.274.120]
Bile Duct Neoplasms [C04.588.274.120.250]
Digestive System Diseases [C06]
Biliary Tract Diseases [C06.130]
Bile Duct Diseases [C06.130.120]
Bile Duct Neoplasms [C06.130.120.120]
Biliary Tract Neoplasms [C06.130.320]
Bile Duct Neoplasms [C06.130.320.120]
Digestive System Neoplasms [C06.301]
Biliary Tract Neoplasms [C06.301.120]
Bile Duct Neoplasms [C06.301.120.250]

Below are MeSH descriptors whose meaning is related to "Bile Duct Neoplasms".

Below are MeSH descriptors whose meaning is more specific than "Bile Duct Neoplasms".

Bile Duct Neoplasms
Common Bile Duct Neoplasms

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Bile Duct Neoplasms" by people in this website by year, and whether "Bile Duct Neoplasms" was a major or minor topic of these publications.

Bar chart showing 25 publications over 17 distinct years, with a maximum of 3 publications in 1996 and 2014 and 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	1	0	1
1996	3	0	3
1997	0	1	1
1998	1	0	1
1999	1	0	1
2000	1	0	1
2001	2	0	2
2008	1	0	1
2009	0	1	1
2010	1	0	1
2012	1	0	1
2014	2	1	3
2019	1	0	1
2021	0	1	1
2022	3	0	3
2023	1	1	2
2024	1	0	1

Below are the most recent publications written about "Bile Duct Neoplasms" by people in Profiles.

Marya NB, Powers PD, Bois MC, Hartley C, Kerr SE, Thangaiah JJ, Norton D, Abu Dayyeh BK, Cantley R, Chandrasekhara V, Gores G, Gleeson FC, Law RJ, Maleki Z, Martin JA, Pantanowitz L, Petersen B, Storm AC, Levy MJ, Graham RP. Utilization of an artificial intelligence-enhanced, web-based application to review bile duct brushing cytologic specimens: A pilot study. Cancer Cytopathol. 2024 Dec; 132(12):779-787.

View in: PubMed
Fujii-Lau LL, Thosani NC, Al-Haddad M, Acoba J, Wray CJ, Zvavanjanja R, Amateau SK, Buxbaum JL, Calderwood AH, Chalhoub JM, Coelho-Prabhu N, Desai M, Elhanafi SE, Fishman DS, Forbes N, Jamil LH, Jue TL, Kohli DR, Kwon RS, Law JK, Lee JK, Machicado JD, Marya NB, Pawa S, Ruan W, Sawhney MS, Sheth SG, Storm A, Thiruvengadam NR, Qumseya BJ. American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in the diagnosis of malignancy in biliary strictures of undetermined etiology: summary and recommendations. Gastrointest Endosc. 2023 Nov; 98(5):685-693.

View in: PubMed
Marya NB, Hartley C, Powers PD, Bois MC, Kerr SE, Graham RP, Levy MJ. Development of a Computer-aided Prediction Tool for Evaluating Brushing Samples of Biliary Strictures. Clin Gastroenterol Hepatol. 2024 01; 22(1):185-187.e3.

View in: PubMed
Wu Q, Zhen Y, Shi L, Vu P, Greninger P, Adil R, Merritt J, Egan R, Wu MJ, Yin X, Ferrone CR, Deshpande V, Baiev I, Pinto CJ, McLoughlin DE, Walmsley CS, Stone JR, Gordan JD, Zhu AX, Juric D, Goyal L, Benes CH, Bardeesy N. EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion-Positive Cholangiocarcinoma. Cancer Discov. 2022 05 02; 12(5):1378-1395.

View in: PubMed
Wu MJ, Shi L, Merritt J, Zhu AX, Bardeesy N. Biology of IDH mutant cholangiocarcinoma. Hepatology. 2022 05; 75(5):1322-1337.

View in: PubMed
Wu MJ, Shi L, Dubrot J, Merritt J, Vijay V, Wei TY, Kessler E, Olander KE, Adil R, Pankaj A, Tummala KS, Weeresekara V, Zhen Y, Wu Q, Luo M, Shen W, Garc?a-Beccaria M, Fern?ndez-Vaquero M, Hudson C, Ronseaux S, Sun Y, Saad-Berreta R, Jenkins RW, Wang T, Heikenw?lder M, Ferrone CR, Goyal L, Nicolay B, Deshpande V, Kohli RM, Zheng H, Manguso RT, Bardeesy N. Mutant IDH Inhibits IFN?-TET2 Signaling to Promote Immunoevasion and Tumor Maintenance in Cholangiocarcinoma. Cancer Discov. 2022 03 01; 12(3):812-835.

View in: PubMed
Nasser-Ghodsi N, Mara K, Watt KD. De Novo Colorectal and Pancreatic Cancer in Liver-Transplant Recipients: Identifying the Higher-Risk Populations. Hepatology. 2021 08; 74(2):1003-1013.

View in: PubMed
Mou H, Ozata DM, Smith JL, Sheel A, Kwan SY, Hough S, Kucukural A, Kennedy Z, Cao Y, Xue W. CRISPR-SONIC: targeted somatic oncogene knock-in enables rapid in vivo cancer modeling. Genome Med. 2019 04 16; 11(1):21.

View in: PubMed
Bledsoe JR, Shinagare SA, Deshpande V. Difficult Diagnostic Problems in Pancreatobiliary Neoplasia. Arch Pathol Lab Med. 2015 Jul; 139(7):848-57.

View in: PubMed
Zhu AX, Borger DR, Kim Y, Cosgrove D, Ejaz A, Alexandrescu S, Groeschl RT, Deshpande V, Lindberg JM, Ferrone C, Sempoux C, Yau T, Poon R, Popescu I, Bauer TW, Gamblin TC, Gigot JF, Anders RA, Pawlik TM. Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets. Ann Surg Oncol. 2014 Nov; 21(12):3827-34.

View in: PubMed

People

Explore

Similar Concepts

Top Journals